Kynam Capital Management LP 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Kynam Capital Management LP | 9,239,731 8.360% | 3,384,965 (+57.82%) | Filing |
| 2024-02-14 12:51 pm Purchase | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | Kynam Capital Management LP | 5,854,766 6.800% | 5,854,766 (New Position) | Filing |